Company Performance: Company's financial health, profitability, revenue growth, and debt levels significantly impact investor confidence and stock price.

Industry Trends: The overall performance and outlook of the pharmaceutical industry, including innovation, regulatory changes, and market competition, affect investor sentiment.

Market Sentiment: General investor optimism or pessimism towards the stock market, influenced by economic conditions, global events, and political stability, can drive stock price fluctuations.

Economic Factors: Macroeconomic indicators such as GDP growth, interest rates, inflation, and unemployment rates can influence the attractiveness of stocks and overall market performance.

Regulatory Environment: Government regulations related to drug approvals, pricing, and healthcare policies can impact pharmaceutical company revenues and profitability.

Competitive Landscape: The presence of competing products, the emergence of new technologies, and the market share of competing companies can affect the company's competitive position and stock valuation.

Company News: News about new drug approvals, clinical trial results, partnerships, mergers, acquisitions, or significant corporate announcements can trigger immediate price reactions.

Analyst Ratings: Investment analysts' recommendations, price targets, and research reports can influence investor perceptions and trading activity.

Investor Sentiment: Overall investor attitudes toward the specific stock. If investor believe in the future the value increase, the stock price increase, and vice versa.

Dividend Policy: High Dividends might bring about high stock price and the vice versa.